{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:55Z","timestamp":1707524935157},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,16]]},"DOI":"10.7759\/cureus.36239","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T16:11:25Z","timestamp":1678983085000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Cardiac Sarcoidosis Masquerading As Heart Failure With Ventricular Arrhythmia"],"prefix":"10.7759","author":[{"given":"Kain","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Marvil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavin B","family":"Adhyaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical manifestations, diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert P","year":"2019","unstructured":"Ungprasert P, Ryu JH, Matteson EL. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019, 3:358-75. 10.1016\/j.mayocpiqo.2019.04.006","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262211","article-title":"Cardiac sarcoidosis","volume":"31","author":"Nunes H","year":"2010","unstructured":"Nunes H, Freynet O, Naggara N, et al.. Cardiac sarcoidosis. Semin Respir Crit Care Med. 2010, 31:428-41. 10.1055\/s-0030-1262211","journal-title":"Semin Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.04.004","article-title":"Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New Zealand","volume":"357","author":"Chow KL","year":"2022","unstructured":"Chow KL, O'Donnell JL, Crozier I. Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New Zealand. Int J Cardiol. 2022, 357:128-33. 10.1016\/j.ijcard.2022.04.004","journal-title":"Int J Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis\u2015digest version","volume":"83","author":"Terasaki F","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, et al.. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis\u2015digest version. Circ J. 2019, 83:2329-88.","journal-title":"Circ J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2019.07.007","article-title":"The utility of whole body (18)F-FDG PET-CT in diagnosing isolated cardiac sarcoidosis: The western Australian cardiac sarcoid study","volume":"29","author":"Giudicatti L","year":"2020","unstructured":"Giudicatti L, Marangou J, Nolan D, Dembo L, Baumwol J, Dwivedi G.  The utility of whole body (18)F-FDG PET-CT in diagnosing isolated cardiac sarcoidosis: The western Australian cardiac sarcoid study. Heart Lung Circ. 2020, 29:e1-6. 10.1016\/j.hlc.2019.07.007","journal-title":"Heart Lung Circ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025565","article-title":"Utility of updated Japanese Circulation Society guidelines to diagnose isolated cardiac sarcoidosis","volume":"11","author":"Sato K","year":"2022","unstructured":"Sato K, Kawamatsu N, Yamamoto M, Machino-Ohtsuka T, Ishizu T, Ieda M. Utility of updated Japanese Circulation Society guidelines to diagnose isolated cardiac sarcoidosis. J Am Heart Assoc. 2022, 11:e025565. 10.1161\/JAHA.122.025565","journal-title":"J Am Heart Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent M","year":"2021","unstructured":"Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021, 385:1018-32. 10.1056\/NEJMra2101555","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m K","year":"2019","unstructured":"Ekstr\u00f6m K, Lehtonen J, Nordenswan HK, et al.. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J. 2019, 40:3121-8. 10.1093\/eurheartj\/ehz428","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie DH","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac sarcoidosis. J Am Coll Cardiol. 2016, 68:411-21. 10.1016\/j.jacc.2016.03.605","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin R","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, et al.. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015, 131:624-32. 10.1161\/CIRCULATIONAHA.114.011522","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac358","article-title":"The cardiac sarcoidosis consortium: elucidating a mysterious disease through collaborative research","volume":"43","author":"Kron J","year":"2022","unstructured":"Kron J, Crawford T. The cardiac sarcoidosis consortium: elucidating a mysterious disease through collaborative research. Eur Heart J. 2022, 43:3991-3. 10.1093\/eurheartj\/ehac358","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016258","article-title":"Letter by Al-Kindi and Oliveira regarding article \"cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study\"","volume":"132","author":"Al-Kindi SG","year":"2015","unstructured":"Al-Kindi SG, Oliveira GH. Letter by Al-Kindi and Oliveira regarding article \"cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study\". Circulation. 2015, 132:e211. 10.1161\/CIRCULATIONAHA.115.016258","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2012.10.019","article-title":"Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Dechering DG","year":"2013","unstructured":"Dechering DG, Kochh\u00e4user S, Wasmer K, et al.. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2013, 10:158-64. 10.1016\/j.hrthm.2012.10.019","journal-title":"Heart Rhythm"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich S","year":"2013","unstructured":"Greulich S, Deluigi CC, Gloekler S, et al.. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013, 6:501-11. 10.1016\/j.jcmg.2012.10.021","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-013-0370-6","article-title":"18F-FDG PET\/CT for the assessment of myocardial sarcoidosis","volume":"15","author":"Skali H","year":"2013","unstructured":"Skali H, Schulman AR, Dorbala S. 18F-FDG PET\/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013, 15:352.","journal-title":"Curr Cardiol Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise T","year":"2014","unstructured":"Ise T, Hasegawa T, Morita Y, et al.. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart. 2014, 100:1165-72. 10.1136\/heartjnl-2013-305187","journal-title":"Heart"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta D","year":"2008","unstructured":"Mehta D, Lubitz SA, Frankel Z, et al.. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008, 133:1426-35. 10.1378\/chest.07-2784","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita T","year":"2018","unstructured":"Vita T, Okada DR, Veillet-Chowdhury M, et al.. Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018, 11:e007030. 10.1161\/CIRCIMAGING.117.007030","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review","volume":"76","author":"Trivieri MG","year":"2020","unstructured":"Trivieri MG, Spagnolo P, Birnie D, et al.. Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 76:1878-901. 10.1016\/j.jacc.2020.08.042","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1753466619868935","article-title":"Contemporary optimized practice in the management of pulmonary sarcoidosis","volume":"13","author":"Aryal S","year":"2019","unstructured":"Aryal S, Nathan SD. Contemporary optimized practice in the management of pulmonary sarcoidosis. Ther Adv Respir Dis. 2019, 13:1753466619868935. 10.1177\/1753466619868935","journal-title":"Ther Adv Respir Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/144034-a-case-of-cardiac-sarcoidosis-masquerading-as-heart-failure-with-ventricular-arrhythmia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:07Z","timestamp":1707508507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/144034-a-case-of-cardiac-sarcoidosis-masquerading-as-heart-failure-with-ventricular-arrhythmia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.36239","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}